Due to their evolutionary bias as ligands
for biologically relevant
drug targets, natural products offer a unique opportunity as lead
compounds in drug discovery. Given the involvement of dopamine receptors
in various physiological and behavioral functions, they are linked
to numerous diseases and disorders such as Parkinson’s disease,
schizophrenia, and substance use disorders. Consequently, ligands
targeting dopamine receptors hold considerable therapeutic and investigative
promise. As this perspective will highlight, dopamine receptor targeting
natural products play a pivotal role as scaffolds with unique and
beneficial pharmacological properties, allowing for natural product-inspired
drug design and lead optimization. As such, dopamine receptor targeting
natural products still have untapped potential to aid in the treatment
of disorders and diseases related to central nervous system (CNS)
and peripheral nervous system (PNS) dysfunction.